Government knew of marijuana’s healing properties for 30 yearsPosted by talesfromtheconspiratum on May 11, 2015
Posted in: Activism , Alternative media , Alternative medicine , Cannabinoids , Cannabis , Cannabis oil , Criminology , Disinformation , Greed , Health , Marijuana , Medical marijuana , Medicine , Mind control , Politics , War on drugs . Leave a comment
For more than 30 years, in fact, the Feds have known full well that cannabis contains unique cannabinoid compounds and antioxidants that act as natural neuroprotectants, protecting the human brain and body against disease. Take a look at the following patent, dated October 7, 2003, which describes in further detail how cannabis is a powerful antioxidant herb — no, cannabis is not an illicit “drug,” as many people have been falsely led to believe — that has a wide range of applications in the treatment and prevention of chronic disease:
As you’ll notice, a host of oxidation-associated diseases, including various ischemic, inflammatory and autoimmune diseases, are referenced in the federal government’s patent as responding positively to cannabis treatment. So why, then, is cannabis still considered to be a Schedule I drug with “no currently accepted medical use and a high potential for abuse”? This is the million-dollar question that deserves an answer, especially as thousands of Americans continue to be locked away in cages for possessing and using this all-natural, medicinal herb that’s completely safe and effective.
Don’t believe the lies: THC isn’t bad, and it offers its own unique medicinal benefits in addition to CBDA recent episode of Ben Swann’s Truth In Media program addresses this important issue head-on, pointing out that the government hypocritically condemns cannabis in the public realm while privately holding a patent on its medicinal use. In fact, the government holds two patents on the medicinal use of cannabis, both filed more than 15 years ago in 1999, that contradict the Department of Justice position that cannabis holds no therapeutic value.
“Our government , through the taxpayer-funded Department of Health and Human Services, holds two patents on cannabinoids and cannabis oil to treat certain diseases like Alzheimer’s and autoimmune diseases like Crohn’s disease,” explains Swann during the segment, which also addresses the blatant hypocrisy of all the low-THC, CBD oil bills becoming law, mostly in Southern states, that unfairly vilify THC as a “bad” cannabinoid.
“Meanwhile, our government, through taxpayer-funded agencies like the Department of Justice, pursues, arrests and imprisons Americans who would attempt to access or use cannabis oil to heal their own bodies. Because in public, they claim cannabis oil is not medicine. And in private, they seek to own the rights to that medicine.”
Be sure to watch the full segment with Ben Swann below:
Like the dozens of other cannabinoids found naturally in cannabis, THC, or tetrahydrocannabinol, has its own medicinal value as well that simply can’t be ignored as prohibition comes to its much-welcomed end across the U.S. Both THC and CBD in combination, according to at least one study cited by The Daily Beast, directly target cancer cells. Even the National Institute on Drug Abuse (NIDA) admits that THC has medicinal value, as evidenced by the fact that pharmaceutical products containing it are already on the market.
“THC increases appetite and reduces nausea,” admits NIDA, noting that cannabis has already been shown to be effective in the treatment of autoimmune diseases like HIV/AIDS, multiple sclerosis and Alzheimer’s disease, as well as conditions associated with chronic inflammation, pain, seizures and even mental disorders.
“THC may also decrease pain, inflammation (swelling and redness), and muscle control problems.”
Furthermore, while the DEA classifies cannabis as a Schedule I drug, the agency classifies crystal methamphetamine, a highly addictive and destructive chemical concoction, as Schedule II and claims it has “less abuse potential” than cannabis.
Thanks to: https://talesfromthelou.wordpress.com